125 related articles for article (PubMed ID: 2550018)
1. Seroprevalence of human parvovirus B19 infection in Sao Tomé and Principe, Malawi and Mascarene Islands.
Schwarz TF; Gürtler LG; Zoulek G; Deinhardt F; Roggendorf M
Zentralbl Bakteriol; 1989 Jul; 271(2):231-6. PubMed ID: 2550018
[TBL] [Abstract][Full Text] [Related]
2. [Parvovirus B19 infections in Germany 1987-1988].
Schwarz TF; Jäger G; Schlipköter UA; Wiersbitzky S; Tiller FW; Hottenträger B; Deinhardt F; Roggendorf M
Offentl Gesundheitswes; 1990 Feb; 52(2):53-7. PubMed ID: 2158028
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil.
Huatuco EM; Durigon EL; Lebrun FL; Passos SD; Gazeta RE; Azevedo Neto RS; Massad E
Rev Saude Publica; 2008 Jun; 42(3):443-9. PubMed ID: 18425294
[TBL] [Abstract][Full Text] [Related]
4. [Seroprevalence of human parvovirus B 19 antibodies (Sticker's disease/erythema infectiosum) in the DRG population].
Wiersbitzky S; Schwarz TF; Bruns R; Jäger G; Bittner S; Weidemann H; Deinhardt F; Hottenträger B; Abel E; Ladstätter L
Kinderarztl Prax; 1990 Apr; 58(4):185-9. PubMed ID: 2164118
[TBL] [Abstract][Full Text] [Related]
5. Human parvovirus B19: ELISA and immunoblot assays.
Schwarz TF; Roggendorf M; Deinhardt F
J Virol Methods; 1988 Jun; 20(2):155-68. PubMed ID: 2843558
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro.
Yaegashi N; Shiraishi H; Tada K; Yajima A; Sugamura K
J Virol Methods; 1989 Nov; 26(2):171-81. PubMed ID: 2559100
[TBL] [Abstract][Full Text] [Related]
7. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay.
Anderson LJ; Tsou C; Parker RA; Chorba TL; Wulff H; Tattersall P; Mortimer PP
J Clin Microbiol; 1986 Oct; 24(4):522-6. PubMed ID: 3021807
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].
Wei Q; Li Y; Wang JW; Wang H; Qu JG; Hung T
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun; 20(2):60-2. PubMed ID: 16816866
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of parvovirus B19 seroprevalence in various age groups in Central Anatolia Region, Turkey].
Türk Dağı H; Ozdemir M; Baykan M; Baysal B
Mikrobiyol Bul; 2010 Jul; 44(3):467-72. PubMed ID: 21063997
[TBL] [Abstract][Full Text] [Related]
10. Parvovirus B19 infection in Hong Kong.
Lim WL; Wong KF; Lau CS
J Infect; 1997 Nov; 35(3):247-9. PubMed ID: 9459396
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of human parvovirus (B19) and rubella virus infections in urban and remote rural areas in northern Brazil.
de Freitas RB; Wong D; Boswell F; de Miranda MF; Linhares AC; Shirley J; Desselberger U
J Med Virol; 1990 Dec; 32(4):203-8. PubMed ID: 1964474
[TBL] [Abstract][Full Text] [Related]
12. [Incidence of parvovirus B19 infection. Seroepidemiologic studies].
Schwarz TF; Roggendorf M; Deinhardt F
Dtsch Med Wochenschr; 1987 Oct; 112(40):1526-31. PubMed ID: 2820687
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil.
Nascimento JP; Buckley MM; Brown KE; Cohen BJ
Rev Inst Med Trop Sao Paulo; 1990; 32(1):41-5. PubMed ID: 2175446
[TBL] [Abstract][Full Text] [Related]
14. Parvovirus B19 antibodies in immunocompromized children in Thailand.
Suandork P; Theamboonlers A; Likitnukul S; Hirsch P; Poovorawan Y
Asian Pac J Allergy Immunol; 2000 Sep; 18(3):161-4. PubMed ID: 11270472
[TBL] [Abstract][Full Text] [Related]
15. New oligopeptide immunoglobulin G test for human parvovirus B19 antibodies.
Schwarz TF; Modrow S; Hottenträger B; Höflacher B; Jäger G; Scharti W; Sumazakl R; Wolf H; Middeldorp J; Roggendorf M
J Clin Microbiol; 1991 Mar; 29(3):431-5. PubMed ID: 1645365
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of parvovirus B19 IgG and IgM antibodies among pregnant women in Oyo State, Nigeria.
Abiodun I; Opaleye OO; Ojurongbe O; Fagbami AH
J Infect Dev Ctries; 2013 Dec; 7(12):946-50. PubMed ID: 24334941
[TBL] [Abstract][Full Text] [Related]
17. Immune response to B19 parvovirus and an antibody defect in persistent viral infection.
Kurtzman GJ; Cohen BJ; Field AM; Oseas R; Blaese RM; Young NS
J Clin Invest; 1989 Oct; 84(4):1114-23. PubMed ID: 2551923
[TBL] [Abstract][Full Text] [Related]
18. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].
González M; Hassanhi M; Rivera S; Bracho MP
Invest Clin; 2000 Mar; 41(1):19-27. PubMed ID: 10758696
[TBL] [Abstract][Full Text] [Related]
19. Seroepidemiology of human parvovirus B19 in Taiwan.
Lin KH; You SL; Chen CJ; Wang CF; Yang CS; Yamazaki S
J Med Virol; 1999 Feb; 57(2):169-73. PubMed ID: 9892403
[TBL] [Abstract][Full Text] [Related]
20. Low prevalence of active parvovirus B19 infection in HIV-infected patients.
Raguin G; Leruez-Ville M; Gregoire V; Deplanche M; Leport C; Morinet F; Vilde JL
Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):760-2. PubMed ID: 9405950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
